Physical Cue‐Based Strategies on Peripheral Nerve Regeneration
Source abstract
Abstract
Abstract Peripheral nerve injury (PNI) remains an intractable challenge in regenerative medicine. Recently, physical cue‐based strategies (e.g., electrical neurostimulation, acoustic radiation, electromagnetic bioregulation, as well as directional fiber guiding, etc.) have drawn increasing attention not only as a stimulator for cell functions modulation and fate determination, but also as a morphology‐index for modulating cell phenotype, proliferation, and differentiation, especially for nerve cells. More importantly, the advanced percutaneous power transmission technology, self‐power nanotechnology that leverages piezoelectrical/triboelectricity materials, and focused ultrasound and pulsed electromagnetic field technology exhibit the appealing practice potential for achieving low‐invasive, wireless, and battery‐free neuromodulation. In this review, recent advances of physical cue‐based strategies including electrical, acoustic, magnetic, and morphology for PNI are systematically overviewed, and the open challenges for realizing scalable clinical/commercial transformation and future perspectives of these strategies for PNI are concluded.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Planarian Biology and Electrostimulation · Tissue Engineering and Regenerative Medicine · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemistry and Chemical Engineering Nanjing University of Science and Technology Nanjing 210094 P. R. China
State Key Laboratory of Bioelectronics Southeast University Nanjing 210096 P. R. China
Funding
National Natural Science Foundation of China · China Postdoctoral Science Foundation · Fundamental Research Funds for the Central Universities
References (100+)
Show source-provided references
1. 10.1002/adma.20220251310.1002/adma.202202513 ↗
2. 10.3390/ijms2215790110.3390/ijms22157901 ↗
3. Chase H. F. · Neurosurgery · 2018 · 85 · 250
4. Michael K. · World Neurosurg · 2018 · 123
5. 10.1021/acsnano.1c1162710.1021/acsnano.1c11627 ↗
6. 10.1088/1758-5090/ac8baa10.1088/1758-5090/ac8baa ↗
7. 10.1002/adfm.20211233110.1002/adfm.202112331 ↗
8. 10.1016/j.carbpol.2022.11944310.1016/j.carbpol.2022.119443 ↗
9. 10.1016/j.cej.2022.13664110.1016/j.cej.2022.136641 ↗
10. 10.1016/j.bioactmat.2021.06.02010.1016/j.bioactmat.2021.06.020 ↗
11. 10.1093/brain/awab24910.1093/brain/awab249 ↗
12. 10.1002/adfm.20220026910.1002/adfm.202200269 ↗
13. Ying M. · Chem. Eng. J. · 2022 · 452
14. 10.1016/j.nanoen.2022.10732210.1016/j.nanoen.2022.107322 ↗
15. 10.1038/s41551-020-0518-910.1038/s41551-020-0518-9 ↗
16. 10.1002/bem.2196610.1002/bem.21966 ↗
17. 10.3389/fncel.2021.81258810.3389/fncel.2021.812588 ↗
18. 10.4103/aja.aja_95_1910.4103/aja.aja_95_19 ↗
19. 10.4103/1673-5374.22876310.4103/1673-5374.228763 ↗
20. 10.1016/j.ultrasmedbio.2021.09.02310.1016/j.ultrasmedbio.2021.09.023 ↗
21. 10.1186/s13287-020-1566-510.1186/s13287-020-1566-5 ↗
22. 10.1016/j.actbio.2018.05.01810.1016/j.actbio.2018.05.018 ↗
23. 10.1016/j.tcb.2020.08.00210.1016/j.tcb.2020.08.002 ↗
24. 10.1016/j.cej.2021.13056310.1016/j.cej.2021.130563 ↗
25. 10.1016/j.actbio.2020.02.00410.1016/j.actbio.2020.02.004 ↗
26. 10.1021/acsmacrolett.1c0053310.1021/acsmacrolett.1c00533 ↗
27. 10.1016/j.bioactmat.2021.04.01910.1016/j.bioactmat.2021.04.019 ↗
28. 10.1002/advs.20210387510.1002/advs.202103875 ↗
29. 10.1016/j.cell.2021.10.02910.1016/j.cell.2021.10.029 ↗
30. 10.1021/acs.jmedchem.9b0086310.1021/acs.jmedchem.9b00863 ↗
31. 10.1016/j.cell.2021.02.03410.1016/j.cell.2021.02.034 ↗
32. 10.1002/adma.20200742910.1002/adma.202007429 ↗
33. 10.1016/j.expneurol.2022.11406910.1016/j.expneurol.2022.114069 ↗
34. 10.4103/1673-5374.32099710.4103/1673-5374.320997 ↗
35. 10.1016/j.nantod.2021.10119610.1016/j.nantod.2021.101196 ↗
36. 10.7150/thno.4091910.7150/thno.40919 ↗
37. 10.1023/A:100701291653010.1023/A:1007012916530 ↗
38. 10.4103/1673-5374.28695610.4103/1673-5374.286956 ↗
39. 10.1177/019262331983899310.1177/0192623319838993 ↗
40. 10.1002/advs.20190051310.1002/advs.201900513 ↗
41. Peiwen C. · Acta Neuropathol. · 2014 · 129 · 97
42. 10.1002/adfm.20210616710.1002/adfm.202106167 ↗
43. 10.3390/ijms2306299610.3390/ijms23062996 ↗
44. Ramesh R. · bioRxiv · 2022 · 42 · 6506
45. 10.1016/j.carbpol.2022.11949910.1016/j.carbpol.2022.119499 ↗
46. Changfeng L. · ACS Biomater. Sci. Eng. · 2018 · 10 · 8227
47. 10.1088/1758-5090/ac57a610.1088/1758-5090/ac57a6 ↗
48. 10.1038/365253a010.1038/365253a0 ↗
49. 10.1038/s41467-019-10881-y10.1038/s41467-019-10881-y ↗
50. 10.1002/mus.2646710.1002/mus.26467 ↗
51. 10.4103/1673-5374.23507310.4103/1673-5374.235073 ↗
52. 10.1016/j.devcel.2022.05.01910.1016/j.devcel.2022.05.019 ↗
53. 10.1016/j.nanoen.2022.10770710.1016/j.nanoen.2022.107707 ↗
54. F.Ye L.Xu X.Li W.Zeng N.Gan C.Zhao W.Yang Y.Jiang J.Guo Proceedings of the National Academy of Sciences of the United States of America 2021 118 2113946118.10.1073/pnas.2113946118 ↗
55. 10.4103/1673-5374.33582310.4103/1673-5374.335823 ↗
56. 10.1002/cbic.20190025910.1002/cbic.201900259 ↗
57. 10.1039/D1TB00054C10.1039/D1TB00054C ↗
58. 10.1002/mabi.20200039110.1002/mabi.202000391 ↗
59. 10.3389/fmats.2021.73468310.3389/fmats.2021.734683 ↗
60. Mohamadi F. · Nanomedicine, and Biotechnology · 2018 · 46 · 34
61. 10.1021/acsnano.1c1050610.1021/acsnano.1c10506 ↗
62. Zhi‐Chao H. · Bioact Mater · 2022 · 22 · 1
63. 10.1002/advs.20210558610.1002/advs.202105586 ↗
64. 10.1016/j.apacoust.2018.07.03510.1016/j.apacoust.2018.07.035 ↗
65. 10.1186/s12951-022-01459-w10.1186/s12951-022-01459-w ↗
66. 10.2147/IJN.S37617210.2147/IJN.S376172 ↗
67. Wang F. · Open Chemistry · 2020 · 35 · 611
68. Pandey S. · J Neuroimmune Pharmacol · 2021 · 1
69. 10.1038/s41598-021-81500-410.1038/s41598-021-81500-4 ↗
70. 10.1002/jnr.2470010.1002/jnr.24700 ↗
71. 10.1213/ANE.000000000000160010.1213/ANE.0000000000001600 ↗
72. 10.1007/s10103-021-03418-710.1007/s10103-021-03418-7 ↗
73. 10.1016/j.ultrasmedbio.2018.09.00510.1016/j.ultrasmedbio.2018.09.005 ↗
74. 10.2334/josnusd.16-062410.2334/josnusd.16-0624 ↗
75. 10.1016/j.archoralbio.2021.10511010.1016/j.archoralbio.2021.105110 ↗
76. 10.1186/s40349-018-0119-110.1186/s40349-018-0119-1 ↗
77. Wenjun X. · VIEW · 2022 · 20220029
78. 10.1007/s12015-022-10332-010.1007/s12015-022-10332-0 ↗
79. 10.1016/j.cej.2021.13182610.1016/j.cej.2021.131826 ↗
80. 10.2147/IJN.S22732810.2147/IJN.S227328 ↗
81. 10.1096/fj.201903005RR10.1096/fj.201903005RR ↗
82. 10.1111/ner.1328710.1111/ner.13287 ↗
83. 10.1177/030006051881741710.1177/0300060518817417 ↗
84. 10.1126/sciadv.abc203610.1126/sciadv.abc2036 ↗
85. 10.1002/cbic.20190068610.1002/cbic.201900686 ↗
86. 10.1016/j.msec.2020.11179110.1016/j.msec.2020.111791 ↗
87. 10.1038/s41467-019-10874-x10.1038/s41467-019-10874-x ↗
88. 10.1038/s41598-017-07968-110.1038/s41598-017-07968-1 ↗
89. Mukund G. · Phys. Rev. E · 2017 · 99
90. 10.1111/cas.1536210.1111/cas.15362 ↗
91. Grudtsyna V. · bioRxiv · 2022 · 501116
92. 10.1016/j.compositesb.2022.10974710.1016/j.compositesb.2022.109747 ↗
93. 10.3390/cells1108131010.3390/cells11081310 ↗
94. 10.1016/j.expneurol.2022.11407010.1016/j.expneurol.2022.114070 ↗
95. 10.1016/j.yexcr.2021.11280510.1016/j.yexcr.2021.112805 ↗
96. Zhaojie W. · Bioact Mater · 2022 · 22 · 75
97. 10.1002/advs.20220005310.1002/advs.202200053 ↗
98. 10.1002/adfm.20220082810.1002/adfm.202200828 ↗
99. 10.1021/acsbiomaterials.8b0156410.1021/acsbiomaterials.8b01564 ↗
100. 10.1016/j.bios.2020.11247010.1016/j.bios.2020.112470 ↗